These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12938075)

  • 21. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
    Omerovic M; Hampel H; Teipel SJ; Buerger K
    World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Realistic expectations for treatment success in Alzheimer's disease.
    Geldmacher DS; Frolich L; Doody RS; Erkinjuntti T; Vellas B; Jones RW; Banerjee S; Lin P; Sano M
    J Nutr Health Aging; 2006; 10(5):417-29. PubMed ID: 17066215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
    Stavitsky K; Brickman AM; Scarmeas N; Torgan RL; Tang MX; Albert M; Brandt J; Blacker D; Stern Y
    Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variability of efficacy measures in Alzheimer's disease].
    Musicco M; Pettenati C; Caltagirone C
    Ann Ist Super Sanita; 2005; 41(1):87-91. PubMed ID: 16037656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer disease and its management: a review.
    Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
    Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study.
    Cortes F; Gillette-Guyonnet S; Nourhashemi F; Andrieu S; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):86-93. PubMed ID: 15791351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000.
    Lopez OL; Becker JT; Sweet RA; Klunk W; Kaufer DI; Saxton J; DeKosky ST
    J Neuropsychiatry Clin Neurosci; 2003; 15(1):67-73. PubMed ID: 12556574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dementia.
    Warner J; Butler R; Jackson E
    Clin Evid; 2002 Dec; (8):927-50. PubMed ID: 12603921
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.
    Cummings J
    J Neuropsychiatry Clin Neurosci; 2021; 33(1):3-13. PubMed ID: 33108950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric aspects of Alzheimer's disease.
    Ballard C; Walker M
    Curr Psychiatry Rep; 1999 Oct; 1(1):49-60. PubMed ID: 11122905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs produce results ... and there's more to come.
    Goldberg RJ
    Behav Healthc Tomorrow; 2000 Aug; 9(4):37-9, 47. PubMed ID: 11067291
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug treatment effects on disease progression.
    Chan PL; Holford NH
    Annu Rev Pharmacol Toxicol; 2001; 41():625-59. PubMed ID: 11264471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinico-genealogical study of Alzheimer's disease.
    Voskresenskaya NI
    Neurosci Behav Physiol; 1991; 21(5):476-82. PubMed ID: 1758628
    [No Abstract]   [Full Text] [Related]  

  • 39. [Health challenges for the year 2000].
    Gonzalo LM
    Rev Med Univ Navarra; 2000; 44(1):53-5. PubMed ID: 11002899
    [No Abstract]   [Full Text] [Related]  

  • 40. [Not Available].
    Duning T
    MMW Fortschr Med; 2024 Apr; 166(7):27-28. PubMed ID: 38637378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.